Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Sabdia MB"'
Autor:
Wight J; Austin Health, Heidelberg, Australia; Olivia Newton John Cancer Research Institute, Victoria, Australia; The University of Melbourne, Melbourne, Australia; Townsville University Hospital, Townsville. joel.wight@health.qld.gov.au., Blombery P; Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia. 7. Princess Alexandra Hospital, Brisbane., Lickiss J; Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria., Burgess M; Princess Alexandra Hospital, Brisbane., Gould C; Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria., Minson A; Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia. 7. Princess Alexandra Hospital, Brisbane., Swain F; Princess Alexandra Hospital, Brisbane., Sabdia MB; Mater Research Institute, The University of Queensland, Brisbane., Gandhi MK; Princess Alexandra Hospital, Brisbane, Australia; Mater Research Institute, The University of Queensland, Brisbane, Australia; University of Queensland, Brisbane., Birchley A; Townsville University Hospital, Townsville., Keane C; Princess Alexandra Hospital, Brisbane, Australia; University of Queensland, Brisbane., Hawkes EA; Austin Health, Heidelberg, Australia; Olivia Newton John Cancer Research Institute, Victoria, Australia; The University of Melbourne, Melbourne, Australia; La Trobe University, Melbourne.
Publikováno v:
Haematologica [Haematologica] 2024 Sep 01; Vol. 109 (9), pp. 3013-3018. Date of Electronic Publication: 2024 Sep 01.
Autor:
Gunawardana J; Blood Cancer Research Group, Mater Research, Translational Research Institute, University of Queensland, Brisbane, Queensland, Australia., Law SC; Blood Cancer Research Group, Mater Research, Translational Research Institute, University of Queensland, Brisbane, Queensland, Australia., Sabdia MB; Blood Cancer Research Group, Mater Research, Translational Research Institute, University of Queensland, Brisbane, Queensland, Australia., Fennell É; School of Medicine, Limerick Digital Cancer Research Centre, Health Research Institute and Bernal Institute, University of Limerick, Limerick, Ireland., Hennessy A; School of Medicine, Limerick Digital Cancer Research Centre, Health Research Institute and Bernal Institute, University of Limerick, Limerick, Ireland., Leahy CI; School of Medicine, Limerick Digital Cancer Research Centre, Health Research Institute and Bernal Institute, University of Limerick, Limerick, Ireland., Murray PG; School of Medicine, Limerick Digital Cancer Research Centre, Health Research Institute and Bernal Institute, University of Limerick, Limerick, Ireland.; Royal College of Surgeons Ireland, Adliya, Bahrain., Bednarska K; Blood Cancer Research Group, Mater Research, Translational Research Institute, University of Queensland, Brisbane, Queensland, Australia., Brosda S; Frazer Institute, Translational Research Institute, University of Queensland, Brisbane, Queensland, Australia., Trotman J; Concord Repatriation General Hospital, University of Sydney, Sydney, New South Wales, Australia.; Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Camperdown, New South Wales, Australia., Berkahn L; Department of Haematology, Auckland City Hospital, Auckland, New Zealand., Zaharia A; Blood Cancer Research Group, Mater Research, Translational Research Institute, University of Queensland, Brisbane, Queensland, Australia., Birch S; Princess Alexandra Hospital, Brisbane, Queensland, Australia., Burgess M; School of Medicine, Limerick Digital Cancer Research Centre, Health Research Institute and Bernal Institute, University of Limerick, Limerick, Ireland.; Princess Alexandra Hospital, Brisbane, Queensland, Australia., Talaulikar D; Haematology Translational Research Unit, ACT Pathology, Canberra Health Services, Canberra, Australian Capital Territory, Australia.; College of Health and Medicine, Australian National University, Canberra, Australian Capital Territory, Australia., Lee JN; Blood Cancer Research Group, Mater Research, Translational Research Institute, University of Queensland, Brisbane, Queensland, Australia., Jude E; Austin Health, Heidelberg, Victoria, Australia., Hawkes EA; Olivia Newton John Cancer Research and Wellness Centre, Austin Health, Melbourne, Victoria, Australia.; Transfusion Research Unit, School of Public Health and Preventative Medicine, Monash University, Melbourne, Victoria, Australia., Jain S; Anatomical Pathology Department, The Canberra Hospital, Canberra, Australian Capital Territory, Australia., Nath K; Blood Cancer Research Group, Mater Research, Translational Research Institute, University of Queensland, Brisbane, Queensland, Australia.; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Snell C; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Mater Pathology, Brisbane, Queensland, Australia., Swain F; Royal College of Surgeons Ireland, Adliya, Bahrain.; Princess Alexandra Hospital, Brisbane, Queensland, Australia., Tobin JWD; Blood Cancer Research Group, Mater Research, Translational Research Institute, University of Queensland, Brisbane, Queensland, Australia.; Princess Alexandra Hospital, Brisbane, Queensland, Australia., Keane C; Frazer Institute, Translational Research Institute, University of Queensland, Brisbane, Queensland, Australia.; Princess Alexandra Hospital, Brisbane, Queensland, Australia., Shanavas M; Blood Cancer Research Group, Mater Research, Translational Research Institute, University of Queensland, Brisbane, Queensland, Australia., Blyth E; Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Camperdown, New South Wales, Australia.; Department of Haematology, Westmead Hospital, Westmead, New South Wales, Australia.; Westmead Institute for Medical Research, The University of Sydney, Westmead, New South Wales, Australia., Steidl C; British Columbia Cancer Agency, Vancouver, British Columbia, Canada., Savage K; British Columbia Cancer Agency, Vancouver, British Columbia, Canada., Farinha P; British Columbia Cancer Agency, Vancouver, British Columbia, Canada., Boyle M; British Columbia Cancer Agency, Vancouver, British Columbia, Canada., Meissner B; British Columbia Cancer Agency, Vancouver, British Columbia, Canada., Green MR; MD Anderson Cancer Center, Houston, Texas, USA., Vega F; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Gandhi MK; Blood Cancer Research Group, Mater Research, Translational Research Institute, University of Queensland, Brisbane, Queensland, Australia.; Princess Alexandra Hospital, Brisbane, Queensland, Australia.
Publikováno v:
American journal of hematology [Am J Hematol] 2024 Aug 17. Date of Electronic Publication: 2024 Aug 17.
Autor:
Bednarska K, Thillaiyampalam G, Mujaj S, Nourse J, Gunawardana J, Sabdia MB, Law SC, Pilaar A, Cui Q, de Long LM, Vari F, Gandhi MK, Cristino AS
Publikováno v:
Acta haematologica [Acta Haematol] 2024 Mar 13. Date of Electronic Publication: 2024 Mar 13.
Autor:
Casey M; Cancer Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia., Segawa K; Cancer Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia., Law SC; Mater Research, The University of Queensland, Brisbane, QLD, Australia., Sabdia MB; Mater Research, The University of Queensland, Brisbane, QLD, Australia., Nowlan B; Cancer Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia., Salik B; Cancer Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia., Lee C; Cancer Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia., Winterford C; Cancer Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia., Pearson S; Cancer Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia., Madore J; Cancer Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia., Dougall WC; Cancer Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia., Gandhi MK; Mater Research, The University of Queensland, Brisbane, QLD, Australia., Nakamura K; Cancer Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia. kyohei.nakamura@qimrberghofer.edu.au.
Publikováno v:
Leukemia [Leukemia] 2023 Feb; Vol. 37 (2), pp. 379-387. Date of Electronic Publication: 2022 Dec 20.
Autor:
Burgess M; Princess Alexandra Hospital, Brisbane, Queensland, Australia.; Diamantina Institute, University of Queensland, Brisbane, Queensland, Australia., Keane C; Princess Alexandra Hospital, Brisbane, Queensland, Australia.; Diamantina Institute, University of Queensland, Brisbane, Queensland, Australia., Tobin JW; Princess Alexandra Hospital, Brisbane, Queensland, Australia.; Mater Research, University of Queensland, Brisbane, Queensland, Australia., Law SC; Mater Research, University of Queensland, Brisbane, Queensland, Australia., Griffin A; Queensland Institute of Medical Research, Herston, Queensland, Australia., Gill D; Princess Alexandra Hospital, Brisbane, Queensland, Australia.; Diamantina Institute, University of Queensland, Brisbane, Queensland, Australia., Ewing AD; Mater Research, University of Queensland, Brisbane, Queensland, Australia., Atkinson V; Princess Alexandra Hospital, Brisbane, Queensland, Australia., Mollee P; Princess Alexandra Hospital, Brisbane, Queensland, Australia.; Diamantina Institute, University of Queensland, Brisbane, Queensland, Australia., Sabdia MB; Mater Research, University of Queensland, Brisbane, Queensland, Australia., Saunders NA; Diamantina Institute, University of Queensland, Brisbane, Queensland, Australia., Gandhi MK; Princess Alexandra Hospital, Brisbane, Queensland, Australia.; Mater Research, University of Queensland, Brisbane, Queensland, Australia.
Publikováno v:
Acta haematologica [Acta Haematol] 2023; Vol. 146 (2), pp. 166-171. Date of Electronic Publication: 2022 Oct 21.
Neoantigens - the next frontier in precision immunotherapy for B-cell lymphoproliferative disorders.
Autor:
Sabdia MB; Mater Research Institute, The University of Queensland, Brisbane, QLD, Australia. Electronic address: m.bilalsabdia@mater.uq.edu.au., Patch AM; QIMR Berghofer Medical Research Institute, Herston, QLD, Australia. Electronic address: ann-marie.patch@qimrberghofer.edu.au., Tsang H; Mater Research Institute, The University of Queensland, Brisbane, QLD, Australia. Electronic address: hennes.tsang@uq.net.au., Gandhi MK; Mater Research Institute, The University of Queensland, Brisbane, QLD, Australia; Department of Haematology, Princess Alexandra Hospital, Brisbane, QLD, Australia. Electronic address: maher.gandhi@mater.uq.edu.au.
Publikováno v:
Blood reviews [Blood Rev] 2022 Nov; Vol. 56, pp. 100969. Date of Electronic Publication: 2022 May 06.
Autor:
Shanavas M; Mater Research University of Queensland Brisbane QLD Australia.; Department of Haematology Mater Hospital Brisbane QLD Australia., Law SC; Mater Research University of Queensland Brisbane QLD Australia., Hertzberg M; Department of Haematology Prince of Wales Hospital and University of NSW Randwick NSW Australia., Hicks RJ; Department of Cancer Imaging Peter MacCallum Cancer Centre East Melbourne Melbourne VIC Australia., Seymour JF; Department of Haematology Peter MacCallum Cancer Centre Royal Melbourne Hospital & University of Melbourne Parkville VIC Australia., Li Z; Centre for Genomics and Personalised Health School of Biomedical Sciences, Faculty of Health Translational Research Institute Queensland University of Technology (QUT) Woolloongabba QLD Australia., Merida de Long L; Mater Research University of Queensland Brisbane QLD Australia., Nath K; Mater Research University of Queensland Brisbane QLD Australia., Sabdia MB; Mater Research University of Queensland Brisbane QLD Australia., Gunawardana J; Mater Research University of Queensland Brisbane QLD Australia., Gandhi MK; Mater Research University of Queensland Brisbane QLD Australia.; Department of Haematology Princess Alexandra Hospital Brisbane QLD Australia., Keane C; Mater Research University of Queensland Brisbane QLD Australia.; Department of Haematology Princess Alexandra Hospital Brisbane QLD Australia.
Publikováno v:
Clinical & translational immunology [Clin Transl Immunology] 2021 Oct 27; Vol. 10 (11), pp. e1351. Date of Electronic Publication: 2021 Oct 27 (Print Publication: 2021).
Autor:
Law SC; Mater Research Institute, The University of Queensland, Brisbane, QLD, Australia., Hoang T; Diamantina Institute, The University of Queensland, Brisbane, QLD, Australia.; Hue University of Medicine and Pharmacy, Hue, Vietnam., O'Rourke K; Mater Research Institute, The University of Queensland, Brisbane, QLD, Australia., Tobin JWD; Mater Research Institute, The University of Queensland, Brisbane, QLD, Australia., Gunawardana J; Mater Research Institute, The University of Queensland, Brisbane, QLD, Australia., Loo-Oey D; Proteomics Core Facility, Translational Research Institute, Woolloongabba, QLD, Australia., Bednarska K; Mater Research Institute, The University of Queensland, Brisbane, QLD, Australia., Merida de Long L; Mater Research Institute, The University of Queensland, Brisbane, QLD, Australia., Sabdia MB; Mater Research Institute, The University of Queensland, Brisbane, QLD, Australia., Hapgood G; Haematology, Princess Alexandra Hospital, Woolloongabba, QLD, Australia., Blyth E; Westmead Institute for Medical Research, University of Sydney, Sydney, NSW, Australia., Clancy L; Cellular Therapies, NSW Government Health Pathology, Westmead, NSW, Australia., Hennig S; Certara Inc., Princeton, New Jersey.; School of Clinical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, QLD, Australia.; Institute of Pharmacy, Freie Universität Berlin, Berlin, Germany., Keane C; Mater Research Institute, The University of Queensland, Brisbane, QLD, Australia.; Haematology, Princess Alexandra Hospital, Woolloongabba, QLD, Australia., Gandhi MK; Mater Research Institute, The University of Queensland, Brisbane, QLD, Australia.; Haematology, Princess Alexandra Hospital, Woolloongabba, QLD, Australia.
Publikováno v:
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons [Am J Transplant] 2021 Oct; Vol. 21 (10), pp. 3465-3471. Date of Electronic Publication: 2021 Jun 11.
Autor:
Nath K; Mater Research Institute, University of Queensland, Brisbane, QLD, Australia., Law SC; Mater Research Institute, University of Queensland, Brisbane, QLD, Australia., Sabdia MB; Mater Research Institute, University of Queensland, Brisbane, QLD, Australia., Gunawardana J; Mater Research Institute, University of Queensland, Brisbane, QLD, Australia., de Long LM; Mater Research Institute, University of Queensland, Brisbane, QLD, Australia., Sester D; TRI Flow Cytometry Suite, Translational Research Institute, Brisbane, QLD, Australia., Shanavas M; Mater Research Institute, University of Queensland, Brisbane, QLD, Australia., Tsang H; Mater Research Institute, University of Queensland, Brisbane, QLD, Australia., Tobin JWD; Mater Research Institute, University of Queensland, Brisbane, QLD, Australia., Halliday SJ; Department of Haematology, Princess Alexandra Hospital, Brisbane, QLD, Australia., Hernandez A; Department of Haematology, Princess Alexandra Hospital, Brisbane, QLD, Australia., Cross D; Department of Haematology, Princess Alexandra Hospital, Brisbane, QLD, Australia., Bird RJ; Department of Haematology, Princess Alexandra Hospital, Brisbane, QLD, Australia., Jain S; ACT Pathology, Canberra Hospital, Canberra, ACT, Australia., Keane C; Mater Research Institute, University of Queensland, Brisbane, QLD, Australia.; Department of Haematology, Princess Alexandra Hospital, Brisbane, QLD, Australia., Talaulikar D; Haematology Translational Research Unit, Canberra Hospital, Canberra, ACT, Australia.; Australian National University, Canberra, ACT, Australia., Trotman J; Department of Haematology, Concord Repatriation General Hospital, Concord, NSW, Australia.; University of Sydney, Concord, NSW, Australia; and., Law P; Department of Medical Imaging, Princess Alexandra Hospital, Brisbane, QLD, Australia., Gandhi MK; Mater Research Institute, University of Queensland, Brisbane, QLD, Australia.; Department of Haematology, Princess Alexandra Hospital, Brisbane, QLD, Australia.
Publikováno v:
Blood advances [Blood Adv] 2021 Jun 22; Vol. 5 (12), pp. 2644-2649.
Autor:
Gandhi MK; Mater Research Institute-University of Queensland (UQ), Brisbane, QLD, Australia.; Haematology, Princess Alexandra Hospital, Brisbane, QLD, Australia., Hoang T; Diamantina Institute-UQ, Brisbane, QLD, Australia.; University of Medicine and Pharmacy, Hue University, Hue, Vietnam., Law SC; Mater Research Institute-University of Queensland (UQ), Brisbane, QLD, Australia., Brosda S; Diamantina Institute-UQ, Brisbane, QLD, Australia., O'Rourke K; Mater Research Institute-University of Queensland (UQ), Brisbane, QLD, Australia., Tobin JWD; Mater Research Institute-University of Queensland (UQ), Brisbane, QLD, Australia., Vari F; Diamantina Institute-UQ, Brisbane, QLD, Australia., Murigneux V; Diamantina Institute-UQ, Brisbane, QLD, Australia., Fink L; Diamantina Institute-UQ, Brisbane, QLD, Australia., Gunawardana J; Mater Research Institute-University of Queensland (UQ), Brisbane, QLD, Australia., Gould C; Diamantina Institute-UQ, Brisbane, QLD, Australia., Oey H; Diamantina Institute-UQ, Brisbane, QLD, Australia., Bednarska K; Mater Research Institute-University of Queensland (UQ), Brisbane, QLD, Australia., Delecluse S; German Cancer Research Centre (DKFZ), Heidelberg, Germany., Trappe RU; German Posttransplant Lymphoproliferative Disease (PTLD) Study Group, Department of Internal Medicine II-Hematology and Oncology, Ev. Diakonie-Krankenhaus, Bremen, Germany., Merida de Long L; Mater Research Institute-University of Queensland (UQ), Brisbane, QLD, Australia., Sabdia MB; Mater Research Institute-University of Queensland (UQ), Brisbane, QLD, Australia., Bhagat G; Herbert Irving Comprehensive Cancer Center, New York, NY., Hapgood G; Haematology, Princess Alexandra Hospital, Brisbane, QLD, Australia., Blyth E; Westmead Institute for Medical Research, University of Sydney, Westmead, NSW, Australia., Clancy L; Cellular Therapies, NSW Government Health Pathology, Westmead, NSW, Australia., Wight J; Haematology, Townsville University Hospital, Townsville, QLD, Australia.; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia., Hawkes E; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia., Rimsza LM; Mayo Clinic, Phoenix, Arizona; and., Maguire A; Mayo Clinic, Phoenix, Arizona; and., Bojarczuk K; Department of Hematology and Oncology, University Medical Center Göttingen, Göttingen, Germany., Chapuy B; Department of Hematology and Oncology, University Medical Center Göttingen, Göttingen, Germany., Keane C; Mater Research Institute-University of Queensland (UQ), Brisbane, QLD, Australia.; Haematology, Princess Alexandra Hospital, Brisbane, QLD, Australia.
Publikováno v:
Blood [Blood] 2021 Mar 18; Vol. 137 (11), pp. 1468-1477.